Hercules Technology Growth Capital, Inc. is a private equity, venture capital, and venture debt firm specializing in providing capital to privately held venture capital and private equity backed companies and select publicly-traded companies. It seeks to provide emerging growth capital with focus on first institutional round (Series A/B). The firm also invests in expansion stage with focus on follow-on rounds of growth capital (Series B-F). It provides seed and early stage financing. It provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition; convertible, subordinated and/or mezzanine loans; domestic and international expansion; growth capital term loans; vendor financing; revenue acceleration by sales and marketing development and manufacturing expansion. It also provides asset-based financing with a focus on cash flow-based customized financing solutions; accounts receivable facilities; equipment loans/leases; equipment; acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory; equipment and infrastructure financing; and facilities build-out and/or expansion. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It offers growth and emerging growth capital and structured debt financing to companies at all stages of development and specializes in venture debt in the forms of senior secured and subordinated working capital loans, senior revolving loans and bridge loans, venture leasing, and select direct equity capital. It also provides private equity financing for recapitalizations, leveraged buyouts, spin-off transactions, mergers and acquisitions, public to private financings, and PIPEs. It invests in debt and equity investments in later stage, venture, and in special opportunities in the lower middle market companies. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. It primarily provides senior secured revolvers and term loans; unitranche and "one-stop" financings; and mezzanine debt, including "last-out" and second lien financings. The firm typically provides non-control financing solutions used for refinancing of existing indebtedness; acquisition financing control buyouts and minority recaps. It prefers to invest in technology, energy technology, life sciences, and manufacturing sectors. Within technology it focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; healthcare services; information services; internet consumer and business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; fuels and power technology; geothermal; advanced materials (bio-chemicals, solar materials); carbon (capture, conversion, and abatement), energy efficiency technologies (smart grid, demand response, and lighting); generation (solar, biomass, bio fuels, and wind); recycling (conversion, diversion, and programs), storage (batteries, fuel cells), technology (management, measurement, controls), transportation (engine design, infrastructure), waste, and water (treatment, waste water, and desalination). Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, development and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. It provides specialized energy technology industry financings with a focus on international special purpose entity financing; pilot and production facility financing; pre-commercialization facility financing; situation-specific financing (satisfying customer contract requirements, pre-funding strategic relationship, etc.); and supplemental joint venture financing. Within life sciences, it provided growth capital financing solutions with a focus on royalty-based financing of existing or future new drugs or medical devices. The firm invests in Israel and also considers investment in the Mid-Atlantic regions particularly in the areas of software, biotech and information services. It seeks to invest in companies with capital needs from $1 million to $30 million and revenues of $10 million to $200 million, generating EBITDA of $2 million to $15 million, focused primarily on business services, communications, electronics, hardware, and healthcare services. It also co-invests with other private equity firms. Hercules Technology Growth Capital, Inc. was founded in December 2003 and is based in Palo Alto, California with additional offices in San Diego, California; Boston, Massachusetts; Waltham, Massachusetts; Boulder, Colorado; Broomfield, Colorado; Costa Mesa, California; McLean, Virginia; Elmhurst, Illinois; Franklin Park, Illinois and New York, New York.